Here, we investigated the gene expression of RAS components (ATP6AP2, AGTR1, AGTR2, ACE, AGT, and REN) in glioblastoma patient samples from The Cancer Genome Atlas (TCGA) and their association with survival outcomes and the expression of TME pathways. The gene discussed is ATP6AP2; the disease is glioblastoma.